US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 8.040
  • +0.020+0.25%
Close Sep 27 16:00 ET
  • 8.040
  • 0.0000.00%
Post 20:02 ET
25.70MMarket Cap-554P/E (TTM)

Aligos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aligos Therapeutics Q2 2024 Earnings Date

Currency：USDAug 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
1.06M
+1.06M
Beat Est.
-100.00%
-84.59%
--
EPS
-4.00
0.75
+4.75
Beat Est.
+62.79%
+106.98%
+118.75%
Analyst Rating
Buy

Aug 31, 2024

Aligos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 333.330K--
--2024/Q3-- / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
May 7, 20242024/Q1986.000K / 0.000--
Mar 12, 20242023/Q42.009M / 1.600M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 333.330K--
--2024/Q3-- / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
May 7, 20242024/Q1986.000K / 0.000--
Mar 12, 20242023/Q42.009M / 1.600M--

Unlock Free Earnings Estimates

Aligos Therapeutics Earnings Reports

  • Aligos Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:21 ET

  • Aligos Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 16:52 ET

  • Aligos Therapeutics | 10-K: FY2023 Annual Report

    Mar 12 16:19 ET

  • Aligos Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:23 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data